The Boston-based company aims to accelerate the drug discovery process for cancer therapies that are both more effective and less toxic.
AI Drug Discovery Startup Valo Raises $190 Million And Unveils Cancer Therapy Programs
Read more on Forbes - AI
The Boston-based company aims to accelerate the drug discovery process for cancer therapies that are both more effective and less toxic.
Read more on Forbes - AI
January 22, 2021, by Graham
Read more on AIMed
January 20, 2021, by Kyle Wiggers
Read more on VentureBeat
January 20, 2021, by Kyle Wiggers
Read more on VentureBeat
December 11, 2020, by New Scientist - Online news
Read more on New Scientist - Online news
November 30, 2020, by Daniel Shapiro, Contributor
Read more on Forbes - AI
November 18, 2020, by Thomas Macaulay
Read more on The Next Web